These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1509406

  • 1. Defibrotide inhibits platelet activation by cathepsin G released from stimulated polymorphonuclear leukocytes.
    Evangelista V, Piccardoni P, de Gaetano G, Cerletti C.
    Thromb Haemost; 1992 Jun 01; 67(6):660-4. PubMed ID: 1509406
    [Abstract] [Full Text] [Related]

  • 2. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.
    Renesto P, Ferrer-Lopez P, Chignard M.
    Lab Invest; 1990 Apr 01; 62(4):409-16. PubMed ID: 2159081
    [Abstract] [Full Text] [Related]

  • 3. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases.
    Evangelista V, Rajtar G, de Gaetano G, White JG, Cerletti C.
    Blood; 1991 Jun 01; 77(11):2379-88. PubMed ID: 1645603
    [Abstract] [Full Text] [Related]

  • 4. Tumor necrosis factor-alpha enhances platelet activation via cathepsin G released from neutrophils.
    Renesto P, Chignard M.
    J Immunol; 1991 Apr 01; 146(7):2305-9. PubMed ID: 2005399
    [Abstract] [Full Text] [Related]

  • 5. Heparin inhibits neutrophil-induced platelet activation via cathepsin G.
    Ferrer-Lopez P, Renesto P, Prevost MC, Gounon P, Chignard M.
    J Lab Clin Med; 1992 Mar 01; 119(3):231-9. PubMed ID: 1541873
    [Abstract] [Full Text] [Related]

  • 6. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH, Cheng JT, Teng CM.
    Eur J Pharmacol; 2005 Sep 05; 519(1-2):158-67. PubMed ID: 16112105
    [Abstract] [Full Text] [Related]

  • 7. Polymorphonuclear leukocyte-platelet interaction: role of P-selectin in thromboxane B2 and leukotriene C4 cooperative synthesis.
    Maugeri N, Evangelista V, Celardo A, Dell'Elba G, Martelli N, Piccardoni P, de Gaetano G, Cerletti C.
    Thromb Haemost; 1994 Sep 05; 72(3):450-6. PubMed ID: 7531878
    [Abstract] [Full Text] [Related]

  • 8. Effect of defibrotide on polymorphonuclear leukocytes: modulation of calcium entry and availability.
    Di Perri T, Pasini FL.
    Semin Thromb Hemost; 1988 Sep 05; 14 Suppl():23-6. PubMed ID: 2848322
    [No Abstract] [Full Text] [Related]

  • 9. Transcellular metabolism of arachidonic acid: increased platelet thromboxane generation in the presence of activated polymorphonuclear leukocytes.
    Maugeri N, Evangelista V, Piccardoni P, Dell'Elba G, Celardo A, de Gaetano G, Cerletti C.
    Blood; 1992 Jul 15; 80(2):447-51. PubMed ID: 1627802
    [Abstract] [Full Text] [Related]

  • 10. Eglin C and heparin inhibition of platelet activation induced by cathepsin G or human neutrophils.
    Renesto P, Ferrer-Lopez P, Chignard M.
    Ann N Y Acad Sci; 1991 Jul 15; 624():321-4. PubMed ID: 2064235
    [No Abstract] [Full Text] [Related]

  • 11. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G.
    Ferrer-Lopez P, Renesto P, Schattner M, Bassot S, Laurent P, Chignard M.
    Am J Physiol; 1990 Jun 15; 258(6 Pt 1):C1100-7. PubMed ID: 2360620
    [Abstract] [Full Text] [Related]

  • 12. Inhibition by heparin of platelet activation induced by neutrophil-derived cathepsin G.
    Evangelista V, Piccardoni P, Maugeri N, De Gaetano G, Cerletti C.
    Eur J Pharmacol; 1992 Jun 17; 216(3):401-5. PubMed ID: 1425930
    [Abstract] [Full Text] [Related]

  • 13. Defibrotide in vitro inhibits neutrophil activation by a Ca++-involving mechanism.
    Di Perri T, Laghi Pasini F, Capecchi PL, Ceccatelli L, Pasqui AL, Orrico A.
    Int J Tissue React; 1987 Jun 17; 9(5):399-406. PubMed ID: 3667109
    [Abstract] [Full Text] [Related]

  • 14. Inhibition by human leukocyte elastase of neutrophil-mediated platelet activation.
    Renesto P, Balloy V, Chignard M.
    Eur J Pharmacol; 1993 Aug 02; 248(2):151-5. PubMed ID: 8223961
    [Abstract] [Full Text] [Related]

  • 15. Progressive inactivation of cathepsin G and elastase released from activated neutrophils in vitro: lack of participation of the neutrophil alpha 1-proteinase inhibitor.
    Renesto P, Chignard M.
    J Lab Clin Med; 1994 Jun 02; 123(6):906-13. PubMed ID: 8201270
    [Abstract] [Full Text] [Related]

  • 16. Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.
    Renesto P, Balloy V, Kamimura T, Masuda K, Imaizumi A, Chignard M.
    Br J Pharmacol; 1993 Apr 02; 108(4):1100-6. PubMed ID: 8097952
    [Abstract] [Full Text] [Related]

  • 17. Platelet activation by polymorphonuclear leukocytes: role of cathepsin G and P-selectin.
    Cerletti C, Evangelista V, Molino M, de Gaetano G.
    Thromb Haemost; 1995 Jul 02; 74(1):218-23. PubMed ID: 8578461
    [No Abstract] [Full Text] [Related]

  • 18. Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for the neutrophil-mediated platelet activation.
    Renesto P, Chignard M.
    Blood; 1993 Jul 01; 82(1):139-44. PubMed ID: 8324217
    [Abstract] [Full Text] [Related]

  • 19. Effects of glycosaminoglycans on platelet and leucocyte function: role of N-sulfation.
    Rajtar G, Marchi E, de Gaetano G, Cerletti C.
    Biochem Pharmacol; 1993 Sep 01; 46(5):958-60. PubMed ID: 8373448
    [Abstract] [Full Text] [Related]

  • 20. Modulation by superoxide anions of neutrophil-mediated platelet activation.
    Renesto P, Si Tahar M, Chignard M.
    Biochem Pharmacol; 1994 Apr 20; 47(8):1401-4. PubMed ID: 8185647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.